lobbying_activities: 2676396
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2676396 | 8dd62ee0-f712-43eb-a87d-aa36d3f2c6b5 | Q3 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2021 | third_quarter | MED | AACC joined with other healthcare groups in writing to the Centers for Medicare and Medicaid Services requesting the agency issue a State Medicaid Director Letter that instructs State Medicaid programs to recognize and process claims submitted with Proprietary Laboratory Analysis (PLA) codes established by the American Medical Associations Current Procedural Terminology (CPT) Editorial Panel. AACC joined with other healthcare groups in writing to the Centers for Medicare and Medicaid Services to express concerns regarding coding changes included in both the 2021 National Correct Coding Initiative (NCCI) Policy Manual for Medicare Services and the 2021 NCCI Policy Manual for Medicaid Services, which took effect January 1, 2021. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2021-10-05T12:23:59.750000-04:00 |